|
|
Line 11: |
Line 11: |
|
| |
|
| ==Chemistry== | | ==Chemistry== |
| 25I-NBOMe or 2C-I-NBOMe is a serotonergic N-benzyl derivative of the substituted phenethylamine psychedelic known as [[2C-I]]. 25I-NBOMe is a substituted phenethylamine with methoxy groups CH<sub>3</sub>O- attached to carbons R<sub>2</sub> and R<sub>5</sub> as well as an iodine atom attached to carbon R<sub>4</sub>. It differs from [[2C-I]] structurally through a substitution on the amine (NH2) with a 2-methoxybenzyl (BOMe) group. 25I-NBOMe shares this 2-methoxybenzyl substitution with other chemicals of the NBOMe family. This NBOMe addition contains a methoxy ether CH<sub>3</sub>O- bound to a benzene ring at R<sub>2</sub>.
| | 25H-NBOMe or 2C-H-NBOMe is a serotonergic N-benzyl derivative of the substituted phenethylamine psychedelic known as [[2C-H]]. 25H-NBOMe is a substituted phenethylamine with methoxy groups CH<sub>3</sub>O- attached to carbons R<sub>2</sub> and R<sub>5</sub> as well as an iodine atom attached to carbon R<sub>4</sub>. It differs from [[2C-H]] structurally through a substitution on the amine (NH2) with a 2-methoxybenzyl (BOMe) group. 25H-NBOMe shares this 2-methoxybenzyl substitution with other chemicals of the NBOMe family. This NBOMe addition contains a methoxy ether CH<sub>3</sub>O- bound to a benzene ring at R<sub>2</sub>. |
|
| |
|
| ==Pharmacology== | | ==Pharmacology== |
| {{Further|Serotonergic psychedelic}} | | {{Further|Serotonergic psychedelic}} |
| 25I-NBOMe has efficacy at the [[serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] where it acts as an unusually potent and selective [[Agonist#Agonists|partial agonist]].<ref name="pmid21174090">Ettrup, A. E. A.; Hansen, M.; Santini, M. A.; Paine, J.; Gillings, N.; Palner, M.; Lehel, S.; Herth, M. M.; Madsen, J. (2010). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers". European Journal of Nuclear Medicine and Molecular Imaging 38 (4): 681–693. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/21174090</ref> However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive.
| | 25H-NBOMe has efficacy at the [[serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] where it acts as an unusually potent and selective [[Agonist#Agonists|partial agonist]]. |
|
| |
|
| Among psychedelics, this compound is considered to be pharmacologically unique in terms of the high potency, affinity, and selectivity with which it binds to the 5-HT2a receptor.<ref name="pmid21174090" /> Contrary to popular belief, it is not a "full agonist"{{citation needed}}, although questions have been raised about how the effects it produces differ from other 5-HT2a partial agonists, which include the range of traditional psychedelics.
| | According to one paper, 25H-NBOMe has stronger affinity than most other members of the NBOMe family.{{citation needed}} |
|
| |
|
| The Ki values of the following targets were greater than 500 Ki: 5-HT1A, D3, H2, 5-HT1D, α1A adrenergic, δ opioid, serotonin reuptake transporter, 5-HT5A, 5-HT1B, D2, 5-HT7, D1, 5-HT3, 5-HT1E, D5, muscarinic M1-M5, H3, and the dopamine reuptake transporter.<ref name="high specific">High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/18468904</ref>
| | However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. |
| {| class="wikitable sortable" style="text-align: right; margin-left: 10px;" | | |
| |+Ki-values<ref>Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21174090</ref><ref name="high specific" />
| | Among psychedelics, this compound is considered to be pharmacologically unique in terms of the high potency, affinity, and selectivity with which it binds to the 5-HT2a receptor.{{citation needed}} Contrary to popular belief, it is not a "full agonist"{{citation needed}}, although questions have been raised about how the effects it produces differ from other 5-HT2a partial agonists, which include the range of traditional psychedelics. |
|
| |
|
| ! scope="col" |Receptor||Ki (nM)|| class="unsortable" |±
| |
| |-
| |
| ! scope="row" |[[5-HT2A|5-HT<sub>2A</sub>]]
| |
| |0.044
| |
| |-
| |
| ! scope="row" |[[5-HT2C|5-HT<sub>2C</sub>]]
| |
| |2
| |
| |-
| |
| ! scope="row" |[[5-HT6|5-HT<sub>6</sub>]]
| |
| |73||12
| |
| |-
| |
| ! scope="row" |[[mu-opioid receptor|μ-opioid]]
| |
| |82||14
| |
| |-
| |
| ! scope="row" |[[Histamine H1 receptor|H<sub>1</sub>]]
| |
| |189||35
| |
| |-
| |
| ! scope="row" |[[5-HT2B|5-HT<sub>2B</sub>]]
| |
| |231||73
| |
| |-
| |
| ! scope="row" |[[Κ-opioid receptor|κ-opioid]]
| |
| |288||50
| |
| |}
| |
|
| |
|
| ==Subjective effects== | | ==Subjective effects== |
| {{Preamble/SubjectiveEffects}} | | {{Preamble/SubjectiveEffects}} |
| | |
| | |
| {{effects/base | | {{effects/base |
|
| |
|